Relapse Refractory Acute Leukemia clinical trials

Explore recruiting relapse refractory acute leukemia clinical trials.

Recruiting relapse refractory acute leukemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapse Refractory Acute Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I, First In Human, open-label study of escalating doses of INA03 administered intravenously as single agent in adult patients with relapse/refractory Acute Leukemia

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Relapse Refractory Acute Leukemia trials by city

Relapse Refractory Acute Leukemia in Toronto Relapse Refractory Acute Leukemia in Vancouver Relapse Refractory Acute Leukemia in Montreal Relapse Refractory Acute Leukemia in Calgary Relapse Refractory Acute Leukemia in Edmonton Relapse Refractory Acute Leukemia in Ottawa Relapse Refractory Acute Leukemia in Winnipeg Relapse Refractory Acute Leukemia in Quebec City Relapse Refractory Acute Leukemia in Hamilton Relapse Refractory Acute Leukemia in Kitchener Relapse Refractory Acute Leukemia in London Relapse Refractory Acute Leukemia in Halifax Relapse Refractory Acute Leukemia in New York Relapse Refractory Acute Leukemia in Los Angeles Relapse Refractory Acute Leukemia in Chicago Relapse Refractory Acute Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease